Deletion of ATGL reduces the mRNA levels of PPAR-target genes, causing impaired mitochondrial substrate oxidation and respiration, excessive lipid accumulation, heart failure, and fatal cardiomyopathy [80]. The gene discussed is PPARA; the disease is cardiomyopathy.